Clinical AI: A Prospective Use Case Based on ClearRead CT
Wednesday, March 14th, 2 – 2:45pm EST
WHAT YOU WILL LEARN
- The role of Clinical Artificial Intelligence in radiology
- The role of simulation and modeling in product development for Clinical AI
- Industry insight regarding the commercialization of Clinical AI in Lung Cancer Screening
- Clinical insight regarding experiences using ClearRead CT, a novel AI application for Chest CT
Steve Worrell, CEO of Riverain Technologies
Steve is an expert in Clinical AI commercialization and heads up a team of passionate employees dedicated to making a difference in the fight against lung disease using state of the art artificial intelligence.
He has over 25 years of experience, working across engineering, sales and marketing.
Riverain Technologies’ solutions are deployed at leading institutions around the world.
Dr. Jared Christensen, Division Chief of Cardiothoracic Imaging, Associate Professor of Radiology, Duke University Medical Center
Dr. Christensen is a leading thoracic radiologist dedicated to providing patients with state of the art imaging technology. He has authored a variety of articles on cardiothoracic disease and routinely speaks on topics in lung cancer screening detection, diagnosis, and treatment.